Tof MRM for the Quantification of Peptide Biomarkers in Human Glioblastoma with the Xevo™ MRT Mass Spectrometer

Applications | 2025 | WatersInstrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, LC/QQQ
Industries
Pharma & Biopharma
Manufacturer
Waters
Downloadable PDF for viewing
 

Similar PDF

MAPPING PHOSPHORYLATION OF PEPTIDE BIOMARKERS CORRESPONDING WITH GLIOBLASTOMA TUMOURS USING DDA AND A NOVEL MRT MASS SPECTROMETER
Mapping phosphorylation of peptide biomarkers corresponding with glioblastoma tumours using data-dependent acquisition and multi-reflecting time-of-flight mass spectrometry
From Extractables Screening to Targeted Leachables Quantitation Using DDA and Tof- MRM on the Xevo™ MRT Mass Spectrometer
A Fully Integrated Qual/Quan Solution from a Single Injection Using Standardized Sample Preparation and Chromatography with a Benchtop MRT Mass Spectrometer